Rivaroxaban Impurity 77 | CAS 34730-20-6 - Request Quote
Rivaroxaban Impurity 77
| SZ CAT No: | SZ-R017129 |
| CAS No | 34730-20-6 |
| Mol.F. | C6H5ClOS |
| Mol.Wt. | 160.6 |
| Inv. Status | In Stock |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Rivaroxaban Impurity 77 is chemically 1-(4-Chlorothiophen-2-yl)ethan-1-one. Rivaroxaban Impurity 77 is supplied with detailed characterization data compliant with regulatory guideline. Rivaroxaban Impurity 77 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Rivaroxaban.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 34730-20-6
Purchase 34730-20-6
Order 34730-20-6
Enquire 34730-20-6
price of 34730-20-6
34730-20-6 Supplier
34730-20-6 Manufacturer
34730-20-6 Exporter
buy high quality Rivaroxaban Impurity 77
Purchase Rivaroxaban Impurity 77
Rivaroxaban Impurity 77 suppliers
Rivaroxaban Impurity 77 manufacturers
Rivaroxaban Impurity 77 price
Order Rivaroxaban Impurity 77
Enquire Rivaroxaban Impurity 77
Rivaroxaban Impurity 77 cost
Rivaroxaban Impurity 77 Supplier
Rivaroxaban Impurity 77 Distributor
Rivaroxaban Impurity 77 for Method Validation
Rivaroxaban Reference Standard
Rivaroxaban Impurity 77 for ANDA Filing
Rivaroxaban Impurity 77 for Forced Degradation Studies
Rivaroxaban Impurity 77 Identification Standards
Rivaroxaban Impurity 77 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.